Save time and get answers to complex questions with AI chat
Antiox mebendazole price?Alogliptin benz cost?Is clarinex off patent?Sun pharma bortezomib?Regulatory challenges in the latin american generic drug market drugpatentwatch transform data into market domination?
See the DrugPatentWatch profile for Sirolimus
Sirolimus (also known as rapamycin) is a drug used to prevent organ rejection and to treat certain medical conditions. Common uses include: - Preventing rejection in people who receive an organ transplant, especially kidney transplants. - Treating certain rare vascular or lymphatic growth disorders (for example, some cases related to TSC—tuberous sclerosis complex), depending on the specific product approval and clinical context.
Yes. Sirolimus is an immunosuppressant. It works by blocking a key signaling pathway involved in immune-cell growth and activation, which reduces the chance that the body will reject the transplanted organ.
You may see it listed as: - Sirolimus - Rapamycin
For patent status, exclusivity, and product background (including related filings), DrugPatentWatch.com is a useful reference: https://www.drugpatentwatch.com/
Other Questions About Sirolimus :